Trxade Group (OTCMKTS:TRXD) Downgraded to Hold at Zacks Investment Research

Trxade Group (OTCMKTS:TRXD) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday, January 5th.

According to Zacks, “Trxade Group, Inc. is a web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. The company’s products and services include Web-based pharmaceutical marketplaces comprising Trxade.com and Trxade.com; Pharmabayonline, which offers access to proprietary pharmaceutical data analytics to the United States-based independent pharmacies; RxGuru, a software as a service-based desktop application that provides daily drug pricing and analytics to the independent pharmacists; and Pinnacle Tek, an information technology consulting and staffing solution. Trxade Group, Inc. is based in Lutz, Florida. “

Other analysts have also issued reports about the stock. ValuEngine raised shares of Trxade Group from a “sell” rating to a “hold” rating in a research note on Thursday, January 4th. Taglich Brothers reissued a “speculative buy” rating on shares of Trxade Group in a research note on Friday, October 6th.

Trxade Group (TRXD) opened at $0.34 on Friday. Trxade Group has a one year low of $0.22 and a one year high of $1.00. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of -0.82.

ILLEGAL ACTIVITY NOTICE: “Trxade Group (OTCMKTS:TRXD) Downgraded to Hold at Zacks Investment Research” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/13/trxade-group-trxd-downgraded-by-zacks-investment-research-to-hold.html.

Trxade Group Company Profile

Trxade Group, Inc (Trxade) designs, develops, owns and operates a business-to-business Web-based marketplace focused on the United States pharmaceutical industry. The Company’s products and services include Trxade.com, InventoryRx.com, Pharmabayonline and RxGuru. Its services are distributed through its online platform.

Get a free copy of the Zacks research report on Trxade Group (TRXD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Trxade Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trxade Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply